New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
10:09 EDTMNKDMannKind rallies after global licensing agreement for Afrezza
The company and Sanofi (SNY) entered into a worldwide exclusive agreement to develop and commercialize Afrezza Inhalation Powder. The stock is up over 15.5% at time of writing to $9.40, off earlier highs. At that price, next resistance is at $9.63. Support is at $9.29.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
05:46 EDTMNKDStocks with implied volatility movement; AMZN MNKD
Subscribe for More Information
March 20, 2015
16:00 EDTMNKDOptions Update; March 20, 2015
Subscribe for More Information
March 18, 2015
09:32 EDTMNKDMannKind faces cash shortfall if $100M debt not settled, TheStreet says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use